Request Trial
ducks-resized-jpeg
enviromantic / iStockphoto.com
10 July 2017

Going it alone: possible outcomes for life sciences

The UK is aiming to leave the EU by March 2019. This means a lot of things are set to change in the next two years.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Novartis win blocks generics relitigating $7.8bn heart drug patent
22 January 2026   A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent.
Americas
Rooted rights: Lessons from plant patent infringement and invalidity cases
22 January 2026   From public use and foreign sales to the challenges of proving infringement, plant patents present unique legal opportunities—and pitfalls—for the agricultural industry, explain Bree Vculek, Gaby Longsworth, and Robert Millonig of Sterne Kessler.
Careers
Cadwalader global head among trio moving to Orrick
22 January 2026   Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and commercial disputes across life sciences and technology.


Editor's picks

Final call: Who are the world’s best in-house counsel?
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

Editor's picks

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Rooted rights: Lessons from plant patent infringement and invalidity cases
Chinese biotech strikes billion dollar deal in nextgen cancer race
Senior USPTO solicitor steps into private practice
Why the US is poised for a patent litigation surge in 2026
From migraine drugs to COVID vaccine spats, US lawsuits pile up
How AI will be shaped by legal and regulatory developments in 2026
‘All voices must be heard’: New CIPA president sets out plans for 2026
Arnold & Porter loses another regulatory partner to growing rival